Scalp Block Versus Scalp Infiltration With Dexmedetomidine and Local Anesthetic for Post Craniotomy Pain

• Status: Completed
• Trial end date: 2015-01-01
• Target enrollment: 0
• Participant gender: All

Summary

This study has been designed to assess the efficacy of dexmedetomidine as an adjuvant to local anaesthetic agent bupivacaine in scalp nerve block and scalp infiltration to control post craniotomy pain.A third group where patients were administered bupivacaine only infiltration has also been created.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: NAVNEH SAMAGH
• Collaborator: Postgraduate Institute of Medical Education and Research, Chandigarh
• Treatments: Anesthetics; Anesthetics, Local; Bupivacaine; Dexmedetomidine

Criteria

Inclusion Criteria:

• Neurosurgical patients

• 18-70 years of age

• ASA class I and II

• Patients undergoing elective craniotomy, who were conscious and oriented to time, person and place and able to understand and use Numerical Rating Scale (NRS)

Exclusion Criteria:

• Patient dull and irritable

• GCS <15

• Craniotomy incision extending beyond scalp (the field of the block) e.g. craniofacial surgery

• Patients treated chronically with analgesics or narcotic medications

• Allergy to local anaesthetics or dexmedetomedine

• Patients planned for post-operative mechanical ventilation

Following patients were excluded from the study during collection of data in the postoperative period:-

• Patients developing fever (≥39°C) in the postoperative period

• Requiring postoperative ventilation (unplanned)

• Having poor cognitive function at 1 hour postoperative period

• GCS <15 in post-operative period.